Suzetrigine vs Oxycodone for Postoperative Pain

This trial aims to determine if suzetrigine manages pain more effectively than oxycodone after knee replacement surgery due to osteoarthritis. Participants will receive either suzetrigine (a new potential drug) with some oxycodone for backup or just oxycodone. The researchers aim to see if suzetrigine can reduce the need for painkillers after surgery. This trial suits those planning a knee replacement due to osteoarthritis, who have not recently used opioids, and who can read and speak English. As a Phase 4 trial, suzetrigine is already FDA-approved and proven effective, and this research helps understand how it benefits more patients.

The trial requires that you have not taken opioids in the 90 days before joining. Other medications are not mentioned, so it's best to ask the trial team for more details.

Earlier studies have shown that suzetrigine works well and is safe for managing post-surgical pain. Research indicates it can reduce the need for opioids, which are strong painkillers with addiction risks. One study found that about 90% of patients using suzetrigine recovered without needing opioids. Additionally, the FDA has approved suzetrigine for pain management, confirming its safety. Overall, current evidence supports suzetrigine as a safe choice for individuals recovering from surgery.¹²³⁴⁵

Most treatments for postoperative pain rely on opioids like oxycodone, which work by blocking pain signals in the brain but come with risks of addiction and side effects. Suzetrigine is unique because it potentially offers effective pain relief with a different mechanism of action, possibly reducing the reliance on opioids. Researchers are excited about suzetrigine because it might provide a safer alternative to traditional opioid treatments, with fewer side effects and lower risk of dependency. This could revolutionize how we manage postoperative pain by offering a more sustainable and safer option.

Research has shown that suzetrigine helps reduce pain after surgery. In studies, it relieved pain more effectively than a placebo for individuals recovering from surgeries like tummy tucks and bunion removals. One study found that nearly 91% of patients managed their pain without needing opioids. In this trial, participants in Group A will receive suzetrigine, with a small supply of Oxycodone as a rescue medication. This suggests that suzetrigine might help people avoid opioid side effects, such as dizziness or addiction. Overall, suzetrigine appears to be a promising pain reliever after surgery.⁵⁶⁷⁸⁹